Table 7.
Mobile glucose biomarkers
| Mobileoutcomes | RCTs (n = 5),n (%) | Observational studies (n = 1),n (%) | Total publications (n = 6),n (%) |
|---|---|---|---|
| Average glucoselevel | 5 (100) | 1 (100) | 6 (100) |
| Meanglucoselevelasmeasured with the use of CGMs | 4 (80) | 1 (100) | 5 (83) |
| Median glucose level | 1 (20) | 0 (0) | 1 (17) |
| Time in range | 4 (80) | 1 (100) | 5 (83) |
| Percentage of time in“normal” blood glucose range (3.9–10 mmol/L or 70–180 mg/dL) | 4 (80) | 1 (100) | 5 (83) |
| Over 24 h | 3 (60) | 1 (100) | 4 (67) |
| During nighttime and evening hours | 1 (20) | 0 (0) | 1 (17) |
| During intervention period | 1 (20) | 0 (0) | 1 (17) |
| Percentage of time spent in hyperglycemic range (>10 mmol/L or 180 mg/dL) | 3 (60) | 1 (100) | 4 (67) |
| Percentage of time spent in hypoglycemic range (<3.9 mmol/L or 70 mg/dL) | 3 (60) | 1 (100) | 4 (67) |
| Mean percent of time with a low glucose level | 1 (20) | 0 (0) | 1 (17) |
| Time in tight glucose target range (4.4–7.8 mmol/L) | 1 (20) | 0 (0) | 1 (17) |
| Percentage of time spent in severe hypoglycemic range (<55 mg/dL) | 1 (20) | 0 (0) | 1 (17) |
| Percentage of time in mild hyperglycemic range (180–250 mg/dL) | 1 (20) | 0 (0) | 1 (17) |
| Number of episodes of severe hypoglycemia | 2 (40) | 1 (100) | 3 (50) |
| Glucose level variability | 2 (40) | 1 (100) | 3 (50) |
| Standard deviation of blood glucose | 2 (40) | 1 (100) | 3 (50) |
| Minimum and maximum glycemic values | 1 (20) | 0 (0) | 1 (17) |
CGMs, continuous glucose monitors.